<DOC>
	<DOCNO>NCT00957983</DOCNO>
	<brief_summary>The purpose study determine whether EP-4 receptor antagonist prevent headache expect Prostaglandin E2 infusion .</brief_summary>
	<brief_title>EP4-receptor Antagonism Prostaglandin E2 ( PGE2 ) Human Headache Model</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Dinoprostone</mesh_term>
	<criteria>Healthy volunteer Tension headache All primary form headache Cardiovascular , Central Nervous system ( CNS ) autoimmune diseases Gastrointestinal disease Previous clinical sign mental illness substance abuse . Participation clinical study medicinal product without regulatory approval marketing authorisation within 1 month prior trial Pregnancy/nursing Daily intake medication ( except oral contraceptive )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>